BeStock  
Markets › Compare › TDOC vs ABCL

TDOC vs ABCL

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TDOC · Teladoc Health$5.56 ▼ 3.64%
ABCL · AbCellera Biologics$12.83 ▼ 2.43%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3592149206263Oct 9, '25Apr 9, '26Oct 7, '26
  • TDOC -37.2%
  • ABCL +117.1%

Head to head

MetricTDOCABCL
Price$5.56$12.83
Change today▼ 3.64%▼ 2.43%
Market cap$1.01B$4.16B
Return, 3 months-39.6%+76.0%
Return, year to date-20.6%+275.1%
Return, 1 year-38.8%+107.9%
P/E (TTM)-5.6-23.8
P/B0.84.6
P/E percentile vs own 5y37th6th
Dividend yield––
Revenue growth (YoY, latest qtr)-4.0%-76.3%
Net profit growth (YoY)-19.1%-59.6%
Gross margin69.0%–
Operating margin-5.9%-318.8%
Net margin-7.1%-248.8%
Return on equity-13.0%-17.3%
Analyst target vs. price+55.9%+29.6%
Analyst buy share40%89%
RSI (14)3454
30-day volatility37.7%61.7%
Max drawdown, 1 year-52.7%-54.9%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ABCL is the largest of the group by market value.
  • ABCL has returned the most over the past year.
  • ABCL carries the lowest trailing P/E.
  • TDOC is growing revenue fastest.
  • TDOC keeps the most profit per dollar of sales.
  • TDOC has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top